Title:
THERAPEUTIC AGENT
Document Type and Number:
WIPO Patent Application WO/2004/096198
Kind Code:
A1
Abstract:
A preventive or therapeutic agent for diseases accompanied by insulin level or insulin response disorder, characterized in that at least one compound selected from the group consisting of chalcone compounds, acetophenone compounds, coumarin compounds, phthalide compounds, derivatives of these and pharmacologically acceptable salts thereof is contained as an active ingredient. There are further provided an insulin-like agent; a food, beverage or feed; a promoter of glucose introjection in cells; and an agent capable of inducing differentiation to lipocytes.
Inventors:
ENOKI TATSUJI (JP)
KOBAYASHI EIJI (JP)
OGAWA KINUKO (JP)
KUDO YOKO (JP)
TANABE MASASHIGE (JP)
SUGIYAMA KATSUMI (JP)
OHNOGI HIROMU (JP)
SAGAWA HIROAKI (JP)
KATO IKUNOSHIN (JP)
KOBAYASHI EIJI (JP)
OGAWA KINUKO (JP)
KUDO YOKO (JP)
TANABE MASASHIGE (JP)
SUGIYAMA KATSUMI (JP)
OHNOGI HIROMU (JP)
SAGAWA HIROAKI (JP)
KATO IKUNOSHIN (JP)
Application Number:
PCT/JP2004/006282
Publication Date:
November 11, 2004
Filing Date:
April 30, 2004
Export Citation:
Assignee:
TAKARA BIO INC (JP)
ENOKI TATSUJI (JP)
KOBAYASHI EIJI (JP)
OGAWA KINUKO (JP)
KUDO YOKO (JP)
TANABE MASASHIGE (JP)
SUGIYAMA KATSUMI (JP)
OHNOGI HIROMU (JP)
SAGAWA HIROAKI (JP)
KATO IKUNOSHIN (JP)
ENOKI TATSUJI (JP)
KOBAYASHI EIJI (JP)
OGAWA KINUKO (JP)
KUDO YOKO (JP)
TANABE MASASHIGE (JP)
SUGIYAMA KATSUMI (JP)
OHNOGI HIROMU (JP)
SAGAWA HIROAKI (JP)
KATO IKUNOSHIN (JP)
International Classes:
A23K1/16; A23L1/30; A61K31/121; A61K31/222; A61K31/341; A61K31/343; A61K31/351; A61K31/352; A61K31/365; A61K31/366; A61K31/381; A61P3/08; A61P3/10; A61P5/50; A61P43/00; C07C49/84; C07C69/017; C07C69/157; C07D307/46; (IPC1-7): A61K31/121; A61K31/222; A61K31/343; A61K31/341; A61K31/365; A61K31/351; A61K31/381; A61K31/366; A61K31/352; A61P43/00; A61P3/10; A61P3/08; A61P5/50; C07D493/08; C07D309/12; C07D311/32; C07C49/84; C07C49/835; C07C69/18; C07C69/157; C07C69/16; C07C205/45; A23L1/30
Domestic Patent References:
| WO2001076580A1 | 2001-10-18 | |||
| WO2003037316A1 | 2003-05-08 |
Foreign References:
| JPH0761927A | 1995-03-07 | |||
| JPH06199695A | 1994-07-19 | |||
| JPH05509078A | 1993-12-16 | |||
| JP2001058969A | 2001-03-06 | |||
| JPH09176010A | 1997-07-08 | |||
| EP0950411A1 | 1999-10-20 | |||
| JPH01207233A | 1989-08-21 | |||
| JPH11507946A | 1999-07-13 | |||
| JPH0665115A | 1994-03-08 | |||
| JPH10511346A | 1998-11-04 | |||
| JP2004018376A | 2004-01-22 | |||
| JPH0827057A | 1996-01-30 |
Other References:
See also references of EP 1623704A4
Attorney, Agent or Firm:
Hosoda, Yoshinori c/o Hosoda International Patent Office (OMM Building 5th Floor P.O. Box 26, 7-31,
Otemae 1-chome, Chuo-k, Osaka-shi Osaka, JP)
Download PDF:
Previous Patent: 5-AZA-7-DEAZAPURINE NUCLEOSIDES FOR TREATING FLAVIVIRIDAE
Next Patent: REGULATION OF GUANINE NUCLEOTIDE EXCHANGE FACTOR
Next Patent: REGULATION OF GUANINE NUCLEOTIDE EXCHANGE FACTOR